Several infectious diseases can be passed on from a pregnant woman to her baby, increasing the risk of miscarriage, birth defects, and developmental problems. These infections—collectively known as TORCH—include toxoplasmosis, other (e.g., syphilis, HIV), rubella (measles), cytomegalovirus (CMV), and herpes simplex virus. Screening for common infectious diseases utilizing the TORCH panel may help to prevent potential birth defects, as some of the TORCH infections can be effectively treated if the mother is diagnosed early in her pregnancy.1
At the completion of this on-demand webinar, viewers will be able to:
- Understand the magnitude, distribution, and prevalence of TORCH infections
- Discuss the etiology and consequences of TORCH infections
- Understand the clinical utility of TORCH serological tests
Charles K. Cooper, MD
Chief Medical Officer, Diagnostics, Siemens Healthineers
Chuck is board-certified in Infectious Diseases and has a sub-specialty certification in HIV Medicine and currently serves as the Chief Medical Officer for Siemens Healthcare Diagnostics, Siemens Healthineers. Prior to joining Siemens Healthineers in October of 2021, he served in various leadership roles at both the US Food and Drug Administration and Becton Dickinson while continuing to provide care to HIV patients in the Baltimore-Washington area.
Chuck graduated from Georgetown University Medical School after which he completed his Internal Medicine residency at Strong Memorial Hospital, University of Rochester.
Currently at Siemens Healthineers, Chuck oversees clinical product development, evidence generation, and externally facing medical/scientific activities as well as contributing to innovation efforts.